CNTA - CIK 0001847903
The table below shows Centessa Pharmaceuticals plc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $62.43M | $50.81M | $44.24M | $105.16M | $395.03M | $127.37M |
| Short-term investments | $214.16M | $195.40M | $206.48M | $179.35M | $123.42M | $167.46M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $348.68M |
| $307.68M |
| $300.36M |
| $347.72M |
| $568.36M |
| $355.50M |
| Property, plant & equipment | $722.00K | $894.00K | $733.00K | $681.00K | $821.00K | $903.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $641.76M | $448.30M | $492.13M | $527.85M | $609.72M | $398.85M |
| Accounts payable | $10.66M | $8.68M | $5.69M | $5.13M | $7.44M | $5.32M |
| Total current liabilities | $36.57M | $29.12M | $29.69M | $24.20M | $26.41M | $26.75M |
| Long-term debt | $110.44M | $109.82M | $109.55M | $109.25M | $75.70M | $76.50M |
| Total liabilities | $154.41M | $146.73M | $147.21M | $141.60M | $110.58M | $111.88M |
| Retained earnings | -$1.27B | -$1.12B | -$1.07B | -$1.01B | -$877.37M | -$834.81M |
| Total equity | $487.35M | $301.57M | $344.92M | $386.25M | $499.14M | $286.96M |